当前位置：
X-MOL 学术
›
GM Crops Food
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Biotechnology in China – regulation, investment, and delayed commercialization
GM Crops & Food ( IF 4.5 ) Pub Date : 2022-05-04 , DOI: 10.1080/21645698.2022.2068336 Zhihua Xiao 1 , William A Kerr 2
更新日期：2022-05-04
GM Crops & Food ( IF 4.5 ) Pub Date : 2022-05-04 , DOI: 10.1080/21645698.2022.2068336 Zhihua Xiao 1 , William A Kerr 2
Affiliation
ABSTRACT
China has been investing heavily in biotechnology to increase agricultural productivity. While a number of Chinese developed GM crops have cleared the required scientific hurdles – some more than a decade ago – commercialization has not been approved. The regulatory regime for GMOs in China is relatively less well understood than that of the US or the EU. This paper provides a systematic overview of China’s regulatory regime, R&D investment and delayed commercialization decisions on biotechnology over the last 40 years and draws some conclusions regarding the likelihood of the commercialization for major GM crops in the future.
京公网安备 11010802027423号